X Corp Fined A650000 by Australian Court Over Child Protection Compliance Failures Affordable Housing Finance Stocks Could Rally Up to 34 Bernstein Suggests OmniWorld to Shutter All Stores After 33 Years as Retail Landscape Shifts RBC Capital and UBS Express Optimism on Chevron Following Recently Released FirstQuarter Performance Pine Labs RVNL Decline LIC Campus Activewear Gain as Earnings Drive Stock Movements US Productivity Growth Slows in Q4 as Labor Costs Accelerate Raising Inflation Watch RANI Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Progress Continues FormFactor Inc Q1 2026 Earnings EPS Surges Past Estimates Sending Shares Higher First National Corporation FXNC Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain HF Foods Group Inc HFFG Q1 2026 Earnings EPS Soars Past Estimates by 175 but Stock Slips Harrow Inc Q1 2026 Earnings Pharmaceutical Firm Misses EPS Estimates by Wide Margin Cheesecake Factory CAKE Q1 2026 Earnings Modest EPS Beat Lifts Shares Revenue Details Not Disclosed Sally Beauty Holdings SBH Edges Higher Amid Consolidation Near Support Wayfair W Surges 52 as Home Goods Sector Shows Renewed Momentum OXLCZ Edges Lower in Quiet Trading as Bond Market Sentiment Remains Cautious Agios Pharmaceuticals AGIO Slips 11 as Stock Hovers Near Key Support Fiverr FVRR Holds Steady Near Key Support as Stock Trades Flat UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline Old Republic International Declines Testing Key Support Levels as ORI Falls 264 Immunovant IMVT Q1 2026 Earnings EPS Miss Driven by Higher RD Investment Stock Holds Steady MSGM Q1 2026 Earnings First Profitability Milestone Despite Market Skepticism HURN Q1 2026 Earnings EPS Beats Estimates as Consulting Services Maintain Momentum Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress Tilray Q1 2026 Earnings EPS Misses Estimates as Losses Widen Timken Q1 2026 Earnings EPS Surprises to the Upside as Operational Discipline Drives Results Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise